| Description | This product is a recombinant human antibody that targets the gH/gL glycoprotein of the Epstein-Barr Virus (EBV). AMMO1 binds to a discontinuous epitope formed by gH and gL at the interface of domain I and domain II. It is proposed that AMMO1 inhibits viral and cellular membrane fusion. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Epstein-Barr Virus (EBV) |
| Epitope | A discontinuous epitope formed by gH and gL at the interface of domain I and domain II |
| Isotype | IgG |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; Neut; Inhib; Block; FuncS |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | EBV gH/gL |
| Alternative Name | Envelope glycoprotein H; Envelope glycoprotein L; gH; gL |
| UniProt | A0A385J8N2 |
